PTEN and prostate cancer: As COX2 inhibition also blocks M2 TAM differentiation [208,209], celecoxib suppressed M2 TAMs and local MDSCs, and subsequently inhibited high-fat diet-mediate inflammation, resulting in tumor regression in Pten-deficient model mice for prostate cancer [151].